Medication info
Lansid Capsule 15 mg (Lansoprazole)

Lansid Capsule 15 mg (Lansoprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole›15mg / 1 capsule
Manufacturer / importer
Korea Pharmaceutical Co., Ltd.
Appearance
A hard capsule with white to pale brown granules in the upper and lower parts being white.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 200301515 · Notified 2003.04.03 · Insurance code 642800370

Summary

Main use
Treatment and prevention of ulcers; Helicobacter pylori eradication; treatment of reflux disease; suppression of excessive gastric acid secretion
Who takes it
Adults · Children
Adult dose
1. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days as needed. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. 4. Maintenance therapy following treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. 5. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. 6. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. Treatment in adults is usually started at 60 mg once daily. The dosage should be adjusted according to the patient's needs, and treatment may be continued as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be divided. Elderly patients: Do not exceed a daily dose of 30 mg.
Child dose
Pediatric and adolescent patients aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Pediatric and adolescent patients aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, weighing 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, weighing more than 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of ulcers; Helicobacter pylori eradication; treatment of reflux disease; suppression of excessive gastric acid secretion

  • Active duodenal ulcers
  • active benign gastric ulcers
  • duodenal ulcers
  • NSAID-induced gastric ulcers
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion states.
View approved original text

This medication is used for short-term treatment of active duodenal ulcers and active benign gastric ulcers and effectively eradicates Helicobacter pylori to prevent recurrence of duodenal ulcers. It is also used for maintenance therapy after treatment of duodenal ulcers and helps treat gastric ulcers induced by nonsteroidal anti-inflammatory drugs and reduces the risk of their occurrence. It is used for short-term treatment of symptoms related to gastroesophageal reflux disease and erosive esophagitis, as well as maintenance therapy after treatment of erosive esophagitis. It is also effective in managing pathological hypersecretion states such as Zollinger-Ellison syndrome. Thus, it is widely used for the treatment and prevention of various gastrointestinal diseases.

How to take

Adult dose

1. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. 2. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. 3. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days as needed. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. 4. Maintenance therapy following treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. 5. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. 6. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. 7. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks 8. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. 9. Maintenance therapy following treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. 10. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies for each patient. Treatment in adults is usually started at 60 mg once daily. The dosage should be adjusted according to the patient's needs, and treatment may be continued as long as it is clinically effective. Doses of 90 mg per dose have been administered up to twice daily. If the daily dose exceeds 120 mg, it should be divided. Elderly patients: Do not exceed a daily dose of 30 mg.

Child dose

Pediatric and adolescent patients aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Pediatric and adolescent patients aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, weighing 30 kg or less — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, weighing more than 30 kg — Short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with specific allergic reactions or hypersensitivity. Pregnant or breastfeeding women, as well as those taking certain antibiotics or other medications, should exercise caution. It should be used cautiously in patients with poor liver function, the elderly, and children or nursing mothers. If serious allergic symptoms such as skin rash, difficulty breathing, or facial swelling occur during treatment, discontinue use immediately and consult a healthcare professional. Additionally, serious side effects such as blood abnormalities, liver dysfunction, or nephritis may rarely occur, so it is important to be alert to changes in symptoms. Regular monitoring of liver and blood conditions is crucial during long-term use. Since this medication inhibits gastric acid secretion, there may be a slight increase in the risk of gastrointestinal bacterial infections, and if symptoms such as diarrhea or abdominal pain persist, notify a healthcare professional. There is a potential for drug interactions, so inform the healthcare provider of all medications being taken, especially when used in combination with certain antibiotics, antiviral agents, or anticoagulants. The risk of fractures may increase with high doses or long-term use, so dosage adjustments and regular monitoring of the condition may be necessary. Dizziness or drowsiness may occur, so caution is needed when driving or operating machinery. In case of overdose, gastric lavage or symptomatic treatment may be required, and the patient should visit a medical institution immediately. The safety of this medication in children has not been sufficiently confirmed, so consulting with a specialist is essential before use. Store in a place inaccessible to children, and do not transfer to other containers.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, hives, systemic rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic hepatic dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membrane colitis, blood in stool, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, carcinoma, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stools, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, gastric stones, pyloric spasm, cholelithiasis, constipation, thirst, dry mouth, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, abdominal distension, gastric nodules, gastric antral polyps, gastroenteritis, gastric-duodenal bleeding, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, glossitis, dry mouth, tongue disease, glossitis, gum bleeding, postprandial somnolence, colitis, vomiting, nausea, gastrointestinal candidiasis, rectal disorders, rectal bleeding, diabetes, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disorders, joint disorders, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, agitation, amnesia, anxiety, apathy, confusion, depression, dizziness, syncope, hallucinations, hemiplegia, increased hostility, decreased libido, increased libido, neurosis, sensory abnormalities, abnormal thoughts, seizures, dementia, depersonalization, diplopia, hyperkinesis, hypertonia, sensory loss, insomnia, sleep disturbances, drowsiness, tremors, acne, hair loss, pruritus, rash, contact dermatitis, skin dryness, nail disorders, skin cancer, skin disease, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, taste abnormalities, tinnitus, vision constriction, urination disorders, renal colic, penile disorders, testicular disorders, urethral pain, polyuria, frequent urination, urinary retention, menstrual abnormalities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatotoxicity, vomiting, pancreatitis, dysgeusia, aplastic anemia, leukopenia, neutropenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorders, urinary retention, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

A hard capsule with white to pale brown granules in the upper and lower parts being white.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.